Retrospective study in a homogenous cohort after RIC stem cell transplantation.
Intensive monitoring of CMV by quantitative PCR.
No impact of CMV infection on the outcome after RIC stem cell transplantation.
No impact of CMV-positive donor on the outcome after RIC stem cell transplantation.
No impact of CMV infection on the occurrence of relapses.